NPTH — NeuPath Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for NeuPath Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	49.6	47.6	60.9	62.7	66.1
Cost of Revenue
Gross Profit	9.96	9.72	11.1	10.8	12.3
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	54.4	52	64.1	66.8	66.8
Operating Profit	-4.71	-4.4	-3.28	-4.1	-0.712
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-5.39	-4.86	-3.25	-4.08	0.055
Provision for Income Taxes
Net Income After Taxes	-5.31	-5.06	-3.23	-4.28	-0.191
Minority Interest
Net Income Before Extraordinary Items
Net Income	-5.31	-5.06	-3.23	-4.14	-0.107
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-5.31	-5.06	-3.23	-4.14	-0.107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.694	-0.15	-0.063	-0.058	-0.008
Dividends per Share